Reaction
Otorrhoea reporting signals
As of the last recalculation, Otorrhoea appears in 1,721 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is DESOXIMETASONE (PRR 16.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Desoximetasone | 26 | 16.7 | 16.8 |
| Infliximab-Dyyb | 29 | 12.2 | 12.2 |
| Ciclesonide | 13 | 11.6 | 11.6 |
| Omalizumab | 70 | 10.3 | 10.3 |
| Fluticasone Furoate And Vilanterol Trifenatate | 19 | 6.4 | 6.5 |
| Riociguat | 15 | 5.6 | 5.6 |
| Palivizumab | 7 | 5.5 | 5.5 |
| Secukinumab | 69 | 5.3 | 5.3 |
| Pseudoephedrine Hcl | 4 | 4.4 | 4.4 |
| Avapritinib | 4 | 4.0 | 4.0 |
| Ixekizumab | 11 | 3.6 | 3.6 |
| Bimekizumab | 6 | 3.4 | 3.4 |
| Dupilumab | 79 | 2.0 | 2.0 |